Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    CJEU's DocMorris Ruling: Where Is The Line For Pharmaceutical Advertising?

    The intersection of pharmaceutical advertising, consumer protection, and internal market freedoms remains a complex legal battleground within the EU. In Apothekerkammer Nordrhein v. DocMorris NV (C-517/23)...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    Draghi Report On EU Competitiveness Offers New Recommendations For Pharma And Biotech

    The European Commission's comprehensive report on the future of European competitiveness has identified critical challenges facing the pharmaceuticals industry as well as among a range of other sectors across Europe.
    European UnionFood, Drugs, Healthcare, Life Sciences
Osborne Clarke LLP
Osborne Clarke LLP
  • Article

    Belgium Creates A New Legal Exemption For Unauthorised Medicines

    A novel form of 'named patient use' mechanism is meant to address special pharma needs and drug shortages
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Brussels Enterprise Court Clarifies Requirements For SPC Manufacturing Waiver

    In a judgment of December 23, 2024, the Dutch-speaking Enterprise Court of Brussels followed the reasoning of a Dutch court earlier in 2024
    BelgiumFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    New Product Liability Regime On The Way

    The European Commission published a draft proposal for a revised Product Liability Directive (the "PLD Proposal") on 28 September 2022, which aims to bring the European Union's...
    European UnionConsumer Protection
    ALTIUS
    ALTIUS
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 79

    This regular update (no. 79 | 16 March 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines,...
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    EU Court Of Justice: Parallel Importer May Not Remove PPP Batch Number

    On 7 December 2023, the EU Court of Justice (‘CJEU') handed down its ruling in case C-830/21 between Syngenta Agro GmbH (‘Syngenta Agro') and Agro Trade Handelsgesellschaft...
    European UnionInternational Law
    ALTIUS
    ALTIUS
  • Article

    CJEU C-793/22 Biohemp – Indoor Cannabis Cultivation: The CJEU Weighs In

    The Cannabis sativa L. plant serves a wide range of purposes, many of which are uncontroversial. It can be grown in the EU, in which context it is commonly called ‘hemp'.
    European UnionCannabis & Hemp
    ALTIUS
    ALTIUS
  • Article

    EU AI Act's 'Deployers' Definition Has Wide-ranging Significance For Life Sciences

    dentifying businesses as deployers of high-risk AI systems is crucial for understanding new regulatory responsibilities
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Supreme Court Acknowledges Objective Justification For Parallel Importation Of Pharmaceuticals

    The Supreme Court recently handed down two judgments on the repackaging of parallel imported pharmaceuticals.
    BelgiumAntitrust/Competition Law
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    A New CE Marking For European Healthcare: When And Why?

    The CE ("Conformité Européenne") marking of conformity is typically required to demonstrate a product's compliance with applicable European Union legislation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    EU General Court Bars Patient Association From Challenging Medicine Authorisation Refusal

    In Case T‑278/25, the EU General Court recently dismissed as inadmissible a challenge brought by a patient advocacy association against the European Commission's refusal to renew the conditional...
    European UnionFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    European Commission Consultation Shapes High-risk AI Classification For Life Sciences In The EU

    Stakeholder input will influence guidelines for AI Act implementation in healthcare and medical technologies
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Comitology After The Lisbon Treaty

    Previous editions of EU Analyst have examined how key decisions on EU environment and life sciences regulation are taken behind closed doors. In the EU legal framework, ‘comitology’ committees (made up of a representative from each EU Member State and chaired by the European Commission) simply implement rules laid down by the Council.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Steptoe LLP
    Steptoe LLP
  • Article

    EU Pharma Package: Advertising Compromise Proposal

    In our ninth alert in this EU Pharma Package Series, we discussed the proposals of the Commission, Council, and Parliament with respect to advertising of medicinal products.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    The European Commission’s Draft Merger Guidelines: Considerations For Technology, Pharmaceutical, And Life Sciences

    The European Commission has published Draft Merger Guidelines consolidating two decades of enforcement practice into a single framework that emphasizes dynamic competition, innovation, and ecosystem effects. While retaining the existing legal test, the guidelines articulate a more explicit analytical approach that brings greater prominence to scale, resilience, and non-price dimensions of competition, with particular implications for technology and life sciences transactions.
    European UnionAntitrust/Competition Law
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    EU Enforces Stricter Liability For Life Sciences Products

    Pharma and medtech companies face enhanced liability under the EU's new directive...
    European UnionConsumer Protection
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    The New EU "Pharma Package": Global (Orphan) Marketing Authorization

    In this fifth alert in our weekly series on the EU Pharma Package, we will delve into the global marketing authorization (GMA) concept which has largely remained untouched in the legislative proposal...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 60

    This regular update (no. 60 | 6 September 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Cybersecurity, Privacy & Data Protection).
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 61

    This regular update (no. 61 | 21 September 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Cybersecurity, Privacy & Data Protection).
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Showing 81–100 of 127 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics